PUBLISHER: Acute Market Reports | PRODUCT CODE: 1340052
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1340052
Veterinary Biomarkers Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
The veterinary biomarkers market is expected to grow at a CAGR of 12.5% during the forecast period of 2023 to 2031, driven by the increasing prevalence of animal diseases and the growing focus on animal healthcare. Biomarkers play a crucial role in veterinary medicine as they help in the early detection, diagnosis, and monitoring of diseases in animals. These biomarkers can be measured in various biological samples, such as blood, urine, and tissues, providing valuable insights into the health status of animals. One of the key factors contributing to the market growth is the rising awareness about zoonotic diseases, which can be transmitted from animals to humans. With the increasing intermingling of humans and animals, there is a growing need to identify and monitor diseases in animals to prevent their transmission to humans. Biomarkers offer a non-invasive and reliable method for disease detection, enabling timely intervention and control measures. Additionally, the demand for personalized veterinary medicine is fuelling the adoption of biomarkers. Just like in human medicine, personalized veterinary medicine aims to provide tailored treatments based on an individual animal's characteristics and specific disease conditions. Biomarkers aid in this process by providing information about an animal's genetic makeup, disease progression, and response to treatment, allowing veterinarians to make informed decisions regarding the most suitable therapies. The veterinary biomarkers market is expected to experience substantial growth in the coming years. Factors such as the increasing pet population, rising expenditure on animal healthcare, and advancements in biomarker research are driving market expansion. Moreover, the development of novel biomarkers and their commercialization for veterinary applications is anticipated to create lucrative opportunities for market players.
Increasing Prevalence of Animal Diseases
The veterinary biomarkers market is driven by the increasing prevalence of animal diseases worldwide. Various factors contribute to the rising incidence of diseases in animals, including changes in environmental conditions, globalization of trade, and intensive farming practices. According to the Food and Agriculture Organization (FAO), animal diseases are responsible for significant economic losses in the livestock industry, with billions of dollars lost annually. The World Organisation for Animal Health (OIE) reports that diseases such as Avian Influenza, African Swine Fever, and Foot and Mouth Disease have been spreading across different regions, affecting large populations of animals. The Centers for Disease Control and Prevention (CDC) highlights the importance of disease surveillance in animals to prevent zoonotic diseases, which can be transmitted from animals to humans.
Growing Focus on Animal Healthcare
There is a growing focus on animal healthcare, leading to increased investments in veterinary medicine and diagnostics. Pet owners and livestock producers are becoming more aware of the importance of preventive healthcare and early disease detection in animals, driving the demand for veterinary biomarkers. The American Pet Products Association (APPA) estimates that pet owners in the United States spent over $100 billion on pet care in 2020, with a significant portion dedicated to veterinary services and diagnostics. Livestock producers are investing in animal health management to improve productivity and ensure the well-being of their herds. This includes regular health monitoring and disease prevention strategies, which often involve the use of biomarkers for early detection.
Advancements in Biomarker Research
Advancements in biomarker research have contributed to the growth of the veterinary biomarkers market. Scientists and researchers are continuously exploring and identifying new biomarkers that can provide valuable insights into animal health, disease progression, and treatment response. Numerous scientific publications focus on the discovery and validation of biomarkers for various animal diseases. These studies highlight the potential of biomarkers in improving diagnostics, monitoring therapeutic efficacy, and predicting disease outcomes. Advances in technologies such as genomics, proteomics, and metabolomics have expanded the possibilities of biomarker discovery and analysis. These technologies enable the identification of specific molecules or patterns of molecules that can serve as biomarkers in veterinary medicine. Veterinary research institutions, academic centres, and industry collaborations are actively engaged in biomarker research, aiming to develop innovative diagnostic tools and personalized treatment approaches for animals.
Regulatory Challenges and Limitations in Biomarker Validation
One of the key restraints in the veterinary biomarkers market is the presence of regulatory challenges and limitations in biomarker validation. The process of validating biomarkers for diagnostic and prognostic purposes requires rigorous scientific evidence and validation studies to ensure their accuracy and reliability. However, the regulatory frameworks and guidelines for biomarkers in veterinary medicine may not be as well-established or standardized compared to human biomarkers, posing challenges to market growth. The lack of standardized protocols for biomarker validation in veterinary medicine can lead to inconsistencies in the performance and interpretation of biomarker-based tests. Regulatory authorities in different regions may have varying requirements and criteria for biomarker validation, making it difficult for manufacturers to navigate the regulatory landscape and obtain necessary approvals. The American Association of Veterinary Laboratory Diagnosticians (AAVLD) acknowledges the need for harmonized guidelines and validation standards for veterinary biomarkers to ensure their clinical utility and accuracy. The process of validating biomarkers can be time-consuming and expensive, requiring large-scale clinical trials and collaborations between academia, industry, and regulatory bodies. These challenges can hinder the development and commercialization of biomarker-based products in the veterinary market. The regulatory challenges and limitations in biomarker validation pose a restraint to the veterinary biomarkers market, highlighting the importance of establishing standardized guidelines and regulatory frameworks to facilitate the development and commercialization of reliable biomarker-based diagnostic tools in veterinary medicine.
The Kits & Reagents Segment Dominates the Product Segment
In the veterinary biomarkers market, the two key product segments are biomarkers and kits & reagents, along with biomarker readers. The biomarkers segment encompasses the actual biomolecules or molecular indicators used for disease detection and monitoring in animals. The kits & reagents segment includes the necessary tools and substances required for biomarker analysis and testing. Biomarker readers, on the other hand, are specialized instruments or devices used to measure and interpret biomarker results. Among these segments, the kits & reagents segment is expected to have the highest revenue in 2022 in the veterinary biomarkers market. This is due to the recurring demand for consumables and reagents required for biomarker analysis and testing in veterinary diagnostics. The increasing adoption of biomarker-based diagnostic tests in veterinary practice contributes to the continuous need for kits and reagents, driving revenue growth in this segment. However, in terms of the highest CAGR during the forecast period of 2023 to 2031, the biomarker readers segment is expected to witness the fastest growth. Biomarker readers offer automated and efficient analysis of biomarker samples, providing accurate and reliable results. The increasing adoption of advanced technologies such as immunoassays, PCR, and spectrophotometry in veterinary diagnostics drives the demand for biomarker readers. Additionally, the growing trend of point-of-care testing and the need for rapid and on-site diagnostics further contribute to the rising demand for biomarker readers, resulting in a high CAGR for this segment.
Disease Diagnostics Tops the Market by Application
In the veterinary biomarkers market, the application segment consists of disease diagnostics, preclinical research, and other applications. Disease diagnostics involves the use of biomarkers for the detection, diagnosis, and monitoring of various diseases in animals. Preclinical research utilizes biomarkers to study diseases, test therapeutic interventions, and evaluate the efficacy of new drugs or treatments. The "others" category encompasses additional applications such as monitoring animal health and wellness, studying the impact of environmental factors on animal health, and genetic screening. Among these segments, the disease diagnostics segment is expected to generate the highest revenue in 2022 in the veterinary biomarkers market. The increasing prevalence of animal diseases and the growing need for accurate and timely diagnosis drive the demand for biomarker-based diagnostic tests in veterinary practice. The ability of biomarkers to provide early disease detection, monitor treatment response, and predict disease outcomes contributes to the revenue growth in this segment. In terms of the highest CAGR during the forecast period of 2023 to 2031, the preclinical research segment is projected to witness the fastest growth. Biomarkers play a crucial role in preclinical research by providing insights into disease mechanisms, enabling the development of targeted therapies, and evaluating the safety and efficacy of new interventions. The demand for biomarkers in preclinical research is driven by the growing focus on drug discovery and development, as well as the need for personalized treatment approaches in veterinary medicine. Additionally, the "others" category is expected to experience steady growth in both revenue and CAGR. Monitoring animal health and wellness using biomarkers is gaining importance as preventive healthcare practices in veterinary medicine become more prevalent. Furthermore, genetic screening for inherited diseases and traits in animals contributes to the applications falling under the "others" category.
North America Remains as the Global Leader
North America held the largest revenue share in 2022 in the veterinary biomarkers market. The region's dominance can be attributed to several factors, including the presence of well-established veterinary healthcare infrastructure, advanced research facilities, and a high level of pet ownership. Moreover, the increasing adoption of advanced diagnostic technologies and the growing focus on personalized veterinary medicine contribute to the market's growth in this region. The Asia Pacific is projected to witness the highest CAGR in the veterinary biomarkers market during the forecast period of 2023 to 2031. The region is experiencing significant economic growth, leading to improved standards of living and increased pet ownership. Rising awareness about animal health and the growing demand for veterinary services drive the adoption of biomarker-based diagnostics in this region. Additionally, the presence of a large population of livestock animals and the need for effective disease management in the agricultural sector further contribute to the market's growth in Asia Pacific. Europe is another significant market for veterinary biomarkers, characterized by a well-developed veterinary healthcare system and stringent regulatory frameworks. The region's high revenue contribution can be attributed to the presence of key market players, continuous advancements in veterinary diagnostics, and the increasing focus on preventive healthcare in animals.
Market to Remain Highly Competitive during the Forecast Period
The veterinary biomarkers market is highly competitive, with several key players actively engaged in the development and commercialization of biomarker-based products for veterinary applications. These companies are focused on implementing strategic initiatives to strengthen their market position and gain a competitive edge. Some of the top players in the veterinary biomarkers market include IDEXX Laboratories, Inc., Zoetis Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., and Bio-Rad Laboratories, Inc. These companies employ various strategies to maintain their market dominance. One key strategy is research and development (R&D) investments. Market leaders invest significantly in R&D activities to develop innovative biomarkers, diagnostic assays, and related technologies for veterinary applications. This helps them stay at the forefront of technological advancements and offers cutting-edge solutions to veterinarians and researchers. Product launches and acquisitions are additional strategies used by leading companies to strengthen their market position. Introducing new biomarker-based products and expanding their product portfolios enable companies to cater to the evolving needs of veterinary professionals and researchers. Acquisitions and mergers help companies gain access to new technologies, resources, and market segments, contributing to their competitive advantage. Furthermore, market players focus on geographical expansions to tap into untapped markets and extend their global footprint. They establish distribution networks, collaborations with local partners, and subsidiaries in emerging regions to cater to the growing demand for veterinary biomarker products.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofVeterinary Biomarkers market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Veterinary Biomarkers market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Animal Type
- Companion Animals
- Dogs
- Cats
- Others
- Production Animals
- Cows
- Pigs
- Others
Product
- Biomarkers, Kits & Reagents
- Biomarker Readers
Application
- Disease Diagnostics
- Preclinical Research
- Others
Disease
- Inflammatory & Infectious Diseases
- Cardiovascular Diseases
- Skeletal Muscle Diseases
- Tumor
- Others
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Veterinary Biomarkers market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Veterinary Biomarkers market?
- Which is the largest regional market for Veterinary Biomarkers market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Veterinary Biomarkers market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Veterinary Biomarkers market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Veterinary Biomarkers Market
- 2.2. Global Veterinary Biomarkers Market, By Animal Type, 2022 (US$ Million)
- 2.3. Global Veterinary Biomarkers Market, By Product, 2022 (US$ Million)
- 2.4. Global Veterinary Biomarkers Market, By Application, 2022 (US$ Million)
- 2.5. Global Veterinary Biomarkers Market, By Disease, 2022 (US$ Million)
- 2.6. Global Veterinary Biomarkers Market, By Geography, 2022 (US$ Million)
- 2.7. Attractive Investment Proposition by Geography, 2022
3. Veterinary Biomarkers Market: Competitive Analysis
- 3.1. Market Positioning of Key Veterinary Biomarkers Market Vendors
- 3.2. Strategies Adopted by Veterinary Biomarkers Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Veterinary Biomarkers Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Veterinary Biomarkers Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Companion Animals
- 5.3.2. Dogs
- 5.3.3. Cats
- 5.3.4. Others
- 5.3.5. Production Animals
- 5.3.6. Cows
- 5.3.7. Pigs
- 5.3.8. Others
6. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Biomarkers, Kits & Reagents
- 6.3.2. Biomarker Readers
7. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Disease Diagnostics
- 7.3.2. Preclinical Research
- 7.3.3. Others
8. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Growth & Revenue Analysis: 2022 Versus 2031
- 8.3. Market Segmentation
- 8.3.1. Inflammatory & Infectious Diseases
- 8.3.2. Cardiovascular Diseases
- 8.3.3. Skeletal Muscle Diseases
- 8.3.4. Tumor
- 8.3.5. Others
9. North America Veterinary Biomarkers Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 9.3. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 9.4. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 9.5. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 9.6.Veterinary Biomarkers Market: By Region, 2021-2031, USD (Million)
- 9.6.1.North America
- 9.6.1.1. U.S.
- 9.6.1.1.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 9.6.1.1.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 9.6.1.1.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 9.6.1.1.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 9.6.1.2. Canada
- 9.6.1.2.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 9.6.1.2.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 9.6.1.2.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 9.6.1.2.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 9.6.1.3. Rest of North America
- 9.6.1.3.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 9.6.1.3.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 9.6.1.3.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 9.6.1.3.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 9.6.1.1. U.S.
- 9.6.1.North America
10. UK and European Union Veterinary Biomarkers Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.3. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.4. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.5. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.Veterinary Biomarkers Market: By Region, 2021-2031, USD (Million)
- 10.6.1.UK and European Union
- 10.6.1.1. UK
- 10.6.1.1.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.1.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.1.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.1.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.2. Germany
- 10.6.1.2.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.2.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.2.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.2.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.3. Spain
- 10.6.1.3.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.3.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.3.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.3.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.4. Italy
- 10.6.1.4.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.4.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.4.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.4.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.5. France
- 10.6.1.5.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.5.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.5.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.5.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.6. Rest of Europe
- 10.6.1.6.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 10.6.1.6.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 10.6.1.6.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 10.6.1.6.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 10.6.1.1. UK
- 10.6.1.UK and European Union
11. Asia Pacific Veterinary Biomarkers Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.3. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.4. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.5. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.Veterinary Biomarkers Market: By Region, 2021-2031, USD (Million)
- 11.6.1.Asia Pacific
- 11.6.1.1. China
- 11.6.1.1.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.1.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.1.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.1.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.2. Japan
- 11.6.1.2.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.2.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.2.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.2.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.3. India
- 11.6.1.3.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.3.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.3.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.3.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.4. Australia
- 11.6.1.4.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.4.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.4.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.4.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.5. South Korea
- 11.6.1.5.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.5.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.5.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.5.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.6. Rest of Asia Pacific
- 11.6.1.6.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 11.6.1.6.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 11.6.1.6.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 11.6.1.6.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 11.6.1.1. China
- 11.6.1.Asia Pacific
12. Latin America Veterinary Biomarkers Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 12.3. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 12.4. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 12.5. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 12.6.Veterinary Biomarkers Market: By Region, 2021-2031, USD (Million)
- 12.6.1.Latin America
- 12.6.1.1. Brazil
- 12.6.1.1.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 12.6.1.1.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 12.6.1.1.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 12.6.1.1.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 12.6.1.2. Mexico
- 12.6.1.2.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 12.6.1.2.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 12.6.1.2.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 12.6.1.2.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 12.6.1.3. Rest of Latin America
- 12.6.1.3.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 12.6.1.3.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 12.6.1.3.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 12.6.1.3.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 12.6.1.1. Brazil
- 12.6.1.Latin America
13. Middle East and Africa Veterinary Biomarkers Market, 2021-2031, USD (Million)
- 13.1. Market Overview
- 13.2. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 13.3. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 13.4. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 13.5. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 13.6.Veterinary Biomarkers Market: By Region, 2021-2031, USD (Million)
- 13.6.1.Middle East and Africa
- 13.6.1.1. GCC
- 13.6.1.1.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 13.6.1.1.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 13.6.1.1.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 13.6.1.1.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 13.6.1.2. Africa
- 13.6.1.2.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 13.6.1.2.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 13.6.1.2.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 13.6.1.2.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 13.6.1.3. Rest of Middle East and Africa
- 13.6.1.3.1. Veterinary Biomarkers Market: By Animal Type, 2021-2031, USD (Million)
- 13.6.1.3.2. Veterinary Biomarkers Market: By Product, 2021-2031, USD (Million)
- 13.6.1.3.3. Veterinary Biomarkers Market: By Application, 2021-2031, USD (Million)
- 13.6.1.3.4. Veterinary Biomarkers Market: By Disease, 2021-2031, USD (Million)
- 13.6.1.1. GCC
- 13.6.1.Middle East and Africa
14. Company Profile
- 14.1. IDEXX Laboratories, Inc.
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
- 14.2. Zoetis Inc.
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
- 14.3. Thermo Fisher Scientific Inc.
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
- 14.4. Randox Laboratories Ltd.
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
- 14.5. Bio-Rad Laboratories, Inc.
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
- 14.6. Other Notable Players
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 2 Global Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 3 Global Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 4 Global Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 5 North America Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 6 North America Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 7 North America Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 8 North America Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 9 U.S. Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 10 U.S. Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 11 U.S. Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 12 U.S. Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 13 Canada Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 14 Canada Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 15 Canada Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 16 Canada Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 17 Rest of North America Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 18 Rest of North America Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 19 Rest of North America Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 20 Rest of North America Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 21 UK and European Union Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 22 UK and European Union Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 23 UK and European Union Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 24 UK and European Union Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 25 UK Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 26 UK Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 27 UK Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 28 UK Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 29 Germany Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 30 Germany Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 31 Germany Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 32 Germany Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 33 Spain Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 34 Spain Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 35 Spain Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 36 Spain Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 37 Italy Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 38 Italy Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 39 Italy Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 40 Italy Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 41 France Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 42 France Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 43 France Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 44 France Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 45 Rest of Europe Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 46 Rest of Europe Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 47 Rest of Europe Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 48 Rest of Europe Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 49 Asia Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 50 Asia Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 51 Asia Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 52 Asia Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 53 China Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 54 China Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 55 China Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 56 China Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 57 Japan Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 58 Japan Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 59 Japan Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 60 Japan Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 61 India Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 62 India Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 63 India Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 64 India Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 65 Australia Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 66 Australia Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 67 Australia Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 68 Australia Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 69 South Korea Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 70 South Korea Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 71 South Korea Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 72 South Korea Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 73 Latin America Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 74 Latin America Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 75 Latin America Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 76 Latin America Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 77 Brazil Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 78 Brazil Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 79 Brazil Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 80 Brazil Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 81 Mexico Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 82 Mexico Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 83 Mexico Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 84 Mexico Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 85 Rest of Latin America Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 86 Rest of Latin America Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 87 Rest of Latin America Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 88 Rest of Latin America Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 89 Middle East and Africa Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 90 Middle East and Africa Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 91 Middle East and Africa Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 92 Middle East and Africa Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 93 GCC Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 94 GCC Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 95 GCC Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 96 GCC Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 97 Africa Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 98 Africa Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 99 Africa Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 100 Africa Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
- TABLE 101 Rest of Middle East and Africa Veterinary Biomarkers Market By Animal Type, 2021-2031, USD (Million)
- TABLE 102 Rest of Middle East and Africa Veterinary Biomarkers Market By Product, 2021-2031, USD (Million)
- TABLE 103 Rest of Middle East and Africa Veterinary Biomarkers Market By Application, 2021-2031, USD (Million)
- TABLE 104 Rest of Middle East and Africa Veterinary Biomarkers Market By Disease, 2021-2031, USD (Million)
List of Figures
- FIG. 1 Global Veterinary Biomarkers Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Veterinary Biomarkers Market: Quality Assurance
- FIG. 5 Global Veterinary Biomarkers Market, By Animal Type, 2022
- FIG. 6 Global Veterinary Biomarkers Market, By Product, 2022
- FIG. 7 Global Veterinary Biomarkers Market, By Application, 2022
- FIG. 8 Global Veterinary Biomarkers Market, By Disease, 2022
- FIG. 9 Global Veterinary Biomarkers Market, By Geography, 2022
- FIG. 10 Market Geographical Opportunity Matrix - Global Veterinary Biomarkers Market, 2022
FIG. 11Market Positioning of Key Veterinary Biomarkers Market Players, 2022
FIG. 12Global Veterinary Biomarkers Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
- FIG. 13 Global Veterinary Biomarkers Market, By Animal Type, 2022 Vs 2031, %
- FIG. 14 Global Veterinary Biomarkers Market, By Product, 2022 Vs 2031, %
- FIG. 15 Global Veterinary Biomarkers Market, By Application, 2022 Vs 2031, %
- FIG. 16 Global Veterinary Biomarkers Market, By Disease, 2022 Vs 2031, %
- FIG. 17 U.S. Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 18 Canada Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 19 Rest of North America Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 20 UK Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 21 Germany Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 22 Spain Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 23 Italy Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 24 France Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 25 Rest of Europe Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 26 China Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 27 Japan Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 28 India Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 29 Australia Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 30 South Korea Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 31 Rest of Asia Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 32 Brazil Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 33 Mexico Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 34 Rest of Latin America Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 35 GCC Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 36 Africa Veterinary Biomarkers Market (US$ Million), 2021 - 2031
- FIG. 37 Rest of Middle East and Africa Veterinary Biomarkers Market (US$ Million), 2021 - 2031
